ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

SNG Synairgen Plc

4.36
-0.395 (-8.31%)
Last Updated: 08:44:49
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Synairgen Plc LSE:SNG London Ordinary Share GB00B0381Z20 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.395 -8.31% 4.36 4.35 4.69 4.75 4.36 4.75 143,012 08:44:49
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -17.65M -0.0876 -0.50 9.58M
Synairgen Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SNG. The last closing price for Synairgen was 4.76p. Over the last year, Synairgen shares have traded in a share price range of 3.65p to 10.62p.

Synairgen currently has 201,374,975 shares in issue. The market capitalisation of Synairgen is £9.58 million. Synairgen has a price to earnings ratio (PE ratio) of -0.50.

Synairgen Share Discussion Threads

Showing 22101 to 22123 of 99175 messages
Chat Pages: Latest  895  894  893  892  891  890  889  888  887  886  885  884  Older
DateSubjectAuthorDiscuss
18/8/2020
01:06
Welcome back. I told you a long time ago to pile in here!.. I hope you got in before Magic Monday?
dovey21
17/8/2020
22:52
SNG001 is not a treatment for COPD, but viral exacerbations.
wetdream
17/8/2020
20:39
OTC sng looking very strong
stockhunters
17/8/2020
20:19
Strongbuy. On reflection those price targets of yours may not be so nuts after all. How much would an effective treatment for COPD be worth? " • The Global Burden of Disease Study reports a prevalence of 251 million cases of COPD globally in 2016.* Globally, it is estimated that 3.17 million deaths were caused by the disease in 2015 (that is, 5% of all deaths globally in that year)."https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd)So what would a treatment be worth, globally? £2bn to a big pharma? Seems a bit conservative, but let's go with it. And how much for a covid treatment? Double what a COPD treatment is worth, given its contagion and the effect it has on economies? Again, £4bn seems a bit conservative, but let's go with that too. So a treatment - SNG001 - can have a good chance of success at treating two global conditions. £6bn is about £40 a share. And IMO £6bn is *very* conservative. Be interested to hear what others think.
sloppyjoe2
17/8/2020
20:01
Cards on the table, this is going nuts very soon, pile in 😉
strongbuy
17/8/2020
19:43
Dovey it certainly is 😉
strongbuy
17/8/2020
19:42
Sloppy
If we did have any of them then it would not be this price 🚀😉😷

strongbuy
17/8/2020
18:51
Strongbuy......is your Alter ego 'RocketFuel'..something very familiar about your posts! ??
dovey21
17/8/2020
18:48
Strongbuy - we would need pretty spectacular news to get that high: FDA fast-tracking, effectiveness for covid AND COPD, a stonking licensing deal and/or takeover approaches from multiple parties. All possible of course, but at the moment we have none of them...
sloppyjoe2
17/8/2020
18:40
Bignads, I think we could soar to £20-£30 on a good positive news flow 🚀🚀🚀🚀
strongbuy
17/8/2020
18:29
Can't post from the app but v amusing to read all the comments on that thread !!
jjmills56
17/8/2020
18:28
Re Nijjer41 on other thread ...... Wonderful ... my vote goes for NostroNobbus
jjmills56
17/8/2020
17:14
Bignads... interesting choice of user name?
festario
Chat Pages: Latest  895  894  893  892  891  890  889  888  887  886  885  884  Older

Your Recent History

Delayed Upgrade Clock